In HBV-associated HCC, HBV DNA polymerase inhibits the nuclear translocation of PARP1 by interacting with PARP1, thereby upregulating the expression of PD-L1 in tumor cells at the transcriptional level. Here, PARP1 is linked to neoplasm.